JP Patent

JP4081275B2 — ２−オキソ−１−ピロリジン誘導体、それらの製造法、およびそれらの使用

Assigned to ユセベ ファルシム ソシエテ アノニム（アーゲー − リミテッド） · Expires 2008-04-23 · 18y expired

What this patent protects

Patent listed against Briviact.

Drugs covered by this patent

Patent Metadata

Patent number
JP4081275B2
Jurisdiction
JP
Classification
—
Expires
2008-04-23
Drug substance claim
No
Drug product claim
No
Assignee
ユセベ ファルシム ソシエテ アノニム（アーゲー − リミテッド）
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.